share_log

Cyclacel Pharmaceuticals Inc | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(8.0%),Altium Growth Fund, LP EIN:(8.0%), etc.

SEC ·  Jan 10 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more